Insider · CIK 0001727393

Mazar Andrew Paul

Reports to the SEC for 2 companies · FORT WORTH, TX

sec.gov

Transactions

Companies

Filings

CIK

0001727393

Forms 4 and 5

Insider transactions

28 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-04-01	ACTUACTUATE THERAPEUTICS, INC. · Employee Stock Option (right to buy)A Award	Chief Operating Officer	AAward	+105K sh	—	—	105,000
2025-04-01	ACTUACTUATE THERAPEUTICS, INC. · Employee Stock Option (right to buy)A Award	Chief Operating Officer	AAward	+110K sh	—	—	110,346
2025-04-01	ACTUACTUATE THERAPEUTICS, INC. · Employee Stock Option (right to buy)A Award	Chief Operating Officer	AAward	+51K sh	—	—	51,046
2022-03-31	MNPRMonopar TherapeuticsM Exercise/Conversion	Member of 10% Owner Group	MExercise/Conversion	+1,606 sh	—	—	22,595.8
2022-03-31	MNPRMonopar TherapeuticsF Tax Payment	Member of 10% Owner Group	FTax Payment	−471 sh	$2.55	−$1,201.05	22,124.8
2022-03-31	MNPRMonopar Therapeutics · Restricted Stock UnitsM Exercise/Conversion	Member of 10% Owner Group	MExercise/Conversion	−1,606 sh	—	—	88,792
2022-02-02	MNPRMonopar Therapeutics · Stock OptionsA Award	Member of 10% Owner Group	AAward	+88.9K sh	—	—	88,874
2022-02-02	MNPRMonopar Therapeutics · Restricted Stock UnitsA Award	Member of 10% Owner Group	AAward	+67.3K sh	—	—	90,398
2022-01-01	MNPRMonopar Therapeutics · Restricted Stock UnitsM Exercise/Conversion	Member of 10% Owner Group	MExercise/Conversion	−1,937 sh	—	—	3,874
2022-01-01	MNPRMonopar TherapeuticsF Tax Payment	Member of 10% Owner Group	FTax Payment	−671 sh	$3.21	−$2,153.91	20,989.8
2022-01-01	MNPRMonopar TherapeuticsM Exercise/Conversion	Member of 10% Owner Group	MExercise/Conversion	+1,937 sh	—	—	21,660.8
2021-12-31	MNPRMonopar TherapeuticsM Exercise/Conversion	Member of 10% Owner Group	MExercise/Conversion	+1,606 sh	—	—	20,279.8
2021-12-31	MNPRMonopar TherapeuticsF Tax Payment	Member of 10% Owner Group	FTax Payment	−556 sh	$3.21	−$1,784.76	19,723.8
2021-12-31	MNPRMonopar Therapeutics · Restricted Stock UnitsM Exercise/Conversion	Member of 10% Owner Group	MExercise/Conversion	−1,606 sh	—	—	19,273
2021-09-30	MNPRMonopar Therapeutics · Restricted Stock UnitsM Exercise/Conversion	Member of 10% Owner Group	MExercise/Conversion	−1,606 sh	—	—	20,879
2021-09-30	MNPRMonopar TherapeuticsF Tax Payment	Member of 10% Owner Group	FTax Payment	−471 sh	$4.87	−$2,293.77	18,673.8
2021-09-30	MNPRMonopar TherapeuticsM Exercise/Conversion	Member of 10% Owner Group	MExercise/Conversion	+1,606 sh	—	—	19,144.8
2021-06-30	MNPRMonopar TherapeuticsM Exercise/Conversion	Member of 10% Owner Group	MExercise/Conversion	+3,212 sh	—	—	18,480.8
2021-06-30	MNPRMonopar TherapeuticsF Tax Payment	Member of 10% Owner Group	FTax Payment	−942 sh	$5.89	−$5,548.38	17,538.8
2021-06-30	MNPRMonopar Therapeutics · Restricted Stock UnitsM Exercise/Conversion	Member of 10% Owner Group	MExercise/Conversion	−3,212 sh	—	—	22,485
2021-01-26	MNPRMonopar Therapeutics · Stock OptionsA Award	Member of 10% Owner Group	AAward	+36.1K sh	—	—	36,077
2021-01-26	MNPRMonopar Therapeutics · Restricted Stock UnitsA Award	Member of 10% Owner Group	AAward	+25.7K sh	—	—	31,508
2021-01-01	MNPRMonopar TherapeuticsF Tax Payment	Member of 10% Owner Group	FTax Payment	−671 sh	$6.12	−$4,106.52	15,268.8
2021-01-01	MNPRMonopar TherapeuticsM Exercise/Conversion	Member of 10% Owner Group	MExercise/Conversion	+1,937 sh	—	—	15,939.8
2021-01-01	MNPRMonopar Therapeutics · Restricted Stock UnitsM Exercise/Conversion	Member of 10% Owner Group	MExercise/Conversion	−1,937 sh	—	—	5,811
2020-01-31	MNPRMonopar Therapeutics · Stock OptionsA Award	Member of 10% Owner Group	AAward	+32.2K sh	—	—	32,193
2020-01-31	MNPRMonopar Therapeutics · Restricted Stock UnitsA Award	Member of 10% Owner Group	AAward	+7,748 sh	—	—	7,748
2018-08-09	MNPRMonopar Therapeutics · Stock optionsA Award	Member of 10% Owner Group	AAward	+134K sh	—	—	134,300

Recent filings

Accepted (ET)
Apr 14
Mazar Andrew Paul0001683168-26-002581
SEC(opens sec.gov)
Apr 24
Mazar Andrew Paul0001683168-25-002210
SEC(opens sec.gov)
Apr 14
Mazar Andrew Paul0001654954-22-004490
SEC(opens sec.gov)
Feb 44
Mazar Andrew Paul0001654954-22-001174
SEC(opens sec.gov)
Jan 44
Mazar Andrew Paul0001654954-22-000129
SEC(opens sec.gov)
Jan 44
Mazar Andrew Paul0001654954-22-000130
SEC(opens sec.gov)
Oct 14
Mazar Andrew Paul0001654954-21-010720
SEC(opens sec.gov)
Jul 24
Mazar Andrew Paul0001654954-21-007595
SEC(opens sec.gov)

Companies

Address

C/O ACTUATE THERAPEUTICS, INC. 1751 RIVER RUN, SUITE 400

FORT WORTH, TX, 76107